ECONOMIC EVALUATION OF CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY FOR PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW. GLOBEHEAL [Internet]. 2026 Jun. 16 [cited 2026 Aug. 4];9(01):14-30. Available from: https://proceedings.tiikmpublishing.com/index.php/globheal/article/view/1885